List of Excipients in API dapagliflozin and metformin hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing dapagliflozin and metformin hydrochloride
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | XIGDUO | dapagliflozin and metformin hydrochloride | 0310-6270 | ANHYDROUS LACTOSE | |
| AstraZeneca Pharmaceuticals LP | XIGDUO | dapagliflozin and metformin hydrochloride | 0310-6270 | CARBOXYMETHYLCELLULOSE SODIUM | |
| AstraZeneca Pharmaceuticals LP | XIGDUO | dapagliflozin and metformin hydrochloride | 0310-6270 | CELLULOSE, MICROCRYSTALLINE | |
| AstraZeneca Pharmaceuticals LP | XIGDUO | dapagliflozin and metformin hydrochloride | 0310-6270 | CROSPOVIDONE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing dapagliflozin and metformin hydrochloride
Detailed excipient profiles for dapagliflozin and metformin hydrochloride
Excipient focus: ANHYDROUS LACTOSE
dapagliflozin and metformin hydrochloride drug variants containing ANHYDROUS LACTOSE
dapagliflozin and metformin hydrochloride drug variants not containing ANHYDROUS LACTOSE
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
dapagliflozin and metformin hydrochloride drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
dapagliflozin and metformin hydrochloride drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
dapagliflozin and metformin hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
dapagliflozin and metformin hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | dapagliflozin and metformin hydrochloride | 63304-026 |
| >Company | >Ingredient | >NDC |
Excipient focus: COPOVIDONE
dapagliflozin and metformin hydrochloride drug variants containing COPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | dapagliflozin and metformin hydrochloride | 67877-619 |
| >Company | >Ingredient | >NDC |
dapagliflozin and metformin hydrochloride drug variants not containing COPOVIDONE
Excipient focus: CROSCARMELLOSE SODIUM
dapagliflozin and metformin hydrochloride drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | dapagliflozin and metformin hydrochloride | 63304-026 |
| >Company | >Ingredient | >NDC |
dapagliflozin and metformin hydrochloride drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: CROSPOVIDONE
dapagliflozin and metformin hydrochloride drug variants containing CROSPOVIDONE
dapagliflozin and metformin hydrochloride drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | dapagliflozin and metformin hydrochloride | 63304-026 |
| Ascend Laboratories LLC | dapagliflozin and metformin hydrochloride | 67877-619 |
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
dapagliflozin and metformin hydrochloride drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | dapagliflozin and metformin hydrochloride | 33342-406 |
| Ascend Laboratories LLC | dapagliflozin and metformin hydrochloride | 67877-619 |
| >Company | >Ingredient | >NDC |
dapagliflozin and metformin hydrochloride drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FD&C YELLOW NO. 6 ALUMINUM LAKE
dapagliflozin and metformin hydrochloride drug variants containing FD&C YELLOW NO. 6 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | dapagliflozin and metformin hydrochloride | 59651-154 |
| >Company | >Ingredient | >NDC |
dapagliflozin and metformin hydrochloride drug variants not containing FD&C YELLOW NO. 6 ALUMINUM LAKE
Excipient focus: FERRIC OXIDE RED
dapagliflozin and metformin hydrochloride drug variants containing FERRIC OXIDE RED
dapagliflozin and metformin hydrochloride drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
dapagliflozin and metformin hydrochloride drug variants containing FERRIC OXIDE YELLOW
dapagliflozin and metformin hydrochloride drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
dapagliflozin and metformin hydrochloride drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Novadoz Pharmaceuticals LLC | dapagliflozin and metformin hydrochloride | 72205-434 |
| >Company | >Ingredient | >NDC |
dapagliflozin and metformin hydrochloride drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GLYCERYL MONO- AND DICAPRYLOCAPRATE
dapagliflozin and metformin hydrochloride drug variants containing GLYCERYL MONO- AND DICAPRYLOCAPRATE
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | dapagliflozin and metformin hydrochloride | 59651-154 |
| >Company | >Ingredient | >NDC |
dapagliflozin and metformin hydrochloride drug variants not containing GLYCERYL MONO- AND DICAPRYLOCAPRATE
Excipient focus: GLYCERYL MONOCAPRYLOCAPRATE
dapagliflozin and metformin hydrochloride drug variants containing GLYCERYL MONOCAPRYLOCAPRATE
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | dapagliflozin and metformin hydrochloride | 67877-619 |
| >Company | >Ingredient | >NDC |
dapagliflozin and metformin hydrochloride drug variants not containing GLYCERYL MONOCAPRYLOCAPRATE
Excipient focus: HYDROXYPROPYL CELLULOSE
dapagliflozin and metformin hydrochloride drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | dapagliflozin and metformin hydrochloride | 63304-026 |
| >Company | >Ingredient | >NDC |
dapagliflozin and metformin hydrochloride drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYPROMELLOSE
dapagliflozin and metformin hydrochloride drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Novadoz Pharmaceuticals LLC | dapagliflozin and metformin hydrochloride | 72205-434 |
| >Company | >Ingredient | >NDC |
dapagliflozin and metformin hydrochloride drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2208
dapagliflozin and metformin hydrochloride drug variants containing HYPROMELLOSE 2208
dapagliflozin and metformin hydrochloride drug variants not containing HYPROMELLOSE 2208
Excipient focus: HYPROMELLOSE 2910
dapagliflozin and metformin hydrochloride drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | dapagliflozin and metformin hydrochloride | 59651-154 |
| Ascend Laboratories LLC | dapagliflozin and metformin hydrochloride | 67877-619 |
| >Company | >Ingredient | >NDC |
dapagliflozin and metformin hydrochloride drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
dapagliflozin and metformin hydrochloride drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | dapagliflozin and metformin hydrochloride | 33342-406 |
| Lupin Pharmaceuticals Inc | dapagliflozin and metformin hydrochloride | 70748-101 |
| >Company | >Ingredient | >NDC |
dapagliflozin and metformin hydrochloride drug variants not containing HYPROMELLOSES
Excipient focus: LACTOSE MONOHYDRATE
dapagliflozin and metformin hydrochloride drug variants containing LACTOSE MONOHYDRATE
dapagliflozin and metformin hydrochloride drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | dapagliflozin and metformin hydrochloride | 0310-6270 |
| Aurobindo Pharma Limited | dapagliflozin and metformin hydrochloride | 59651-154 |
| Prasco Laboratories | dapagliflozin and metformin hydrochloride | 66993-362 |
| >Company | >Ingredient | >NDC |
Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
dapagliflozin and metformin hydrochloride drug variants containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | dapagliflozin and metformin hydrochloride | 67877-619 |
| >Company | >Ingredient | >NDC |
dapagliflozin and metformin hydrochloride drug variants not containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
Excipient focus: MAGNESIUM STEARATE
dapagliflozin and metformin hydrochloride drug variants containing MAGNESIUM STEARATE
dapagliflozin and metformin hydrochloride drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | dapagliflozin and metformin hydrochloride | 59651-154 |
| >Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
dapagliflozin and metformin hydrochloride drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Macleods Pharmaceuticals Limited | dapagliflozin and metformin hydrochloride | 33342-406 |
| Aurobindo Pharma Limited | dapagliflozin and metformin hydrochloride | 59651-154 |
| >Company | >Ingredient | >NDC |
dapagliflozin and metformin hydrochloride drug variants not containing MANNITOL
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
dapagliflozin and metformin hydrochloride drug variants containing MICROCRYSTALLINE CELLULOSE 101
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | dapagliflozin and metformin hydrochloride | 63304-026 |
| >Company | >Ingredient | >NDC |
dapagliflozin and metformin hydrochloride drug variants not containing MICROCRYSTALLINE CELLULOSE 101
Excipient focus: MICROCRYSTALLINE CELLULOSE 112
dapagliflozin and metformin hydrochloride drug variants containing MICROCRYSTALLINE CELLULOSE 112
| Company | Ingredient | NDC |
|---|---|---|
| Sun Pharmaceutical Industries Inc | dapagliflozin and metformin hydrochloride | 63304-026 |
| >Company | >Ingredient | >NDC |
dapagliflozin and metformin hydrochloride drug variants not containing MICROCRYSTALLINE CELLULOSE 112
Excipient focus: POLYETHYLENE GLYCOL
dapagliflozin and metformin hydrochloride drug variants containing POLYETHYLENE GLYCOL
dapagliflozin and metformin hydrochloride drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYVINYL ALCOHOL
dapagliflozin and metformin hydrochloride drug variants containing POLYVINYL ALCOHOL
dapagliflozin and metformin hydrochloride drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | dapagliflozin and metformin hydrochloride | 0310-6270 |
| Prasco Laboratories | dapagliflozin and metformin hydrochloride | 66993-362 |
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
dapagliflozin and metformin hydrochloride drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | dapagliflozin and metformin hydrochloride | 70748-101 |
| >Company | >Ingredient | >NDC |
dapagliflozin and metformin hydrochloride drug variants not containing POVIDONE
Excipient focus: POVIDONE K90
dapagliflozin and metformin hydrochloride drug variants containing POVIDONE K90
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | dapagliflozin and metformin hydrochloride | 67877-619 |
| >Company | >Ingredient | >NDC |
dapagliflozin and metformin hydrochloride drug variants not containing POVIDONE K90
Excipient focus: SILICON DIOXIDE
dapagliflozin and metformin hydrochloride drug variants containing SILICON DIOXIDE
dapagliflozin and metformin hydrochloride drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
dapagliflozin and metformin hydrochloride drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | dapagliflozin and metformin hydrochloride | 59651-154 |
| Ascend Laboratories LLC | dapagliflozin and metformin hydrochloride | 67877-619 |
| Novadoz Pharmaceuticals LLC | dapagliflozin and metformin hydrochloride | 72205-434 |
| >Company | >Ingredient | >NDC |
dapagliflozin and metformin hydrochloride drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM STEARYL FUMARATE
dapagliflozin and metformin hydrochloride drug variants containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Aurobindo Pharma Limited | dapagliflozin and metformin hydrochloride | 59651-154 |
| Lupin Pharmaceuticals Inc | dapagliflozin and metformin hydrochloride | 70748-101 |
| >Company | >Ingredient | >NDC |
dapagliflozin and metformin hydrochloride drug variants not containing SODIUM STEARYL FUMARATE
Excipient focus: TALC
dapagliflozin and metformin hydrochloride drug variants containing TALC
dapagliflozin and metformin hydrochloride drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | dapagliflozin and metformin hydrochloride | 0310-6270 |
| Prasco Laboratories | dapagliflozin and metformin hydrochloride | 66993-362 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
dapagliflozin and metformin hydrochloride drug variants containing TITANIUM DIOXIDE
dapagliflozin and metformin hydrochloride drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | dapagliflozin and metformin hydrochloride | 0310-6270 |
| Prasco Laboratories | dapagliflozin and metformin hydrochloride | 66993-362 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
